Form D · Other
NATUROMED THERAPEUTICS, LTD.
Pemberton, A1 · CIK 0001899995
Offering snapshot reported Dec 17, 2021 · SEC filing
- Reported sold
- $585K Offering amount: $1.56M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 2, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 17, 2021 | Initial | $585,224 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-425681
CDN$1,999,999.92. Based on the Bank of Canada exchange rate of 0.7803 on December 2, 2021.
Source: Form D, filed Dec 17, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Edward Brown | Director, Executive |
| Meir Bulua | Director |
| Gabriel Glosband | Director, Executive |
| Chanel Alexis Smythe | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1930 Stonecutter Place B134
Pemberton, A1, V0N 1L0
Pemberton, A1, V0N 1L0